By CERBIOS-PHARMA SA
To get in touch with CERBIOS-PHARMA SA, simply fill out the form below.
Subscribe to Supplier
Cerbios-Pharma fielding strong team at Biotech Showcase Digital
Lugano, Switzerland: – Pharmaceutical ingredient and antibody drug conjugate (ADC) specialist Cerbios-Pharma SA (Cerbios) will be a high-profile virtual presence at the upcoming Biotech Showcase Digital online conference.
Cerbios will participate as a leading member of the PROVEO global alliance and Gold Sponsor, with a virtual booth at the event.
The Biotech Showcase will provide Cerbios-Pharma with a platform to present its new and more dynamic online image. It will also contribute a webinar-style presentation to the event with Chief Commercial Officer Denis Angioletti speaking on the PROVEO Alliance offer of a full integrated end-to-end approach to ADC development.
Mr. Angioletti will speak about how antibody drug conjugates, as a rapidly expanding therapeutic class, demand a more systematic approach to development and production than the traditional one of coordinating multiple independent CMOs with consequent complex supply chain.
“I will show how the PROVEO Integrated one-stop-shop solution bypasses this level of complexity by providing a single flexible infrastructure for the whole ADCs value and supply chain,” said Mr. Angioletti.
“This platform guarantees, under a single Service Agreement, a comprehensive solution to ensure coordinated antibody conjugated development, including monoclonal antibody (mAb) development, optimized payload, conjugation, fill-finish manufacturing and shipments,” he explained.
Mr. Angioletti will present a case study of a PROVEO-built fully-aligned quality framework across all functional areas to ensure seamless regulatory clearance and tightly coordinated quality management.”
Online event team
He will be accompanied by Business Development Manager Vitor Sousa and Oncotec New Business Development Manager Matthias Beck in taking part to Biotech Showcase’s online forums and one-to-one digital networking platforms.
Cerbios-Pharma’s PROVEO partners AGC Biologics and Oncotec Pharma Produktion will also participate in the event, together reaching out to HPAPI small molecule and ADC drug developers and biotech innovators seeking end-to-end solutions.
Cerbios is a privately held company located in Lugano, Switzerland, that specializes in the development and manufacturing of both chemical and biological APIs for its partners world-wide.
Exclusive CDMO services are offered for the development and manufacturing of high potency active ingredients (HPAIs) as well as for biological products including monoclonal antibodies, recombinant proteins and antibody drug conjugates (ADCs).
Cerbios provides full CMC support, including the supply of cGMP clinical batches, registration/validation material and commercially manufactured APIs, with paramount ability to support a successful registration. Cerbios is a worldwide presence with partners in Europe, USA and Japan.
Cerbios Division, PROVEO™, in partnership with AGC Biologics and Oncotec, focus on integrated ADC manufacturing solutions.
PROVEO can offer a ADCs end-to-end service from drug substance development till sterile Fill & Finish.
Learn more at: https://cerbios.swiss
About Biotech Showcase Digital 2021
The Biotech Showcase™ Investor conference is co-produced by Demy-Colton and the EBD Group (Informa Connect) as an on-demand networking and knowledge sharing event for the entire biotechnology sector.
The event will include discussion sessions, accessible ‘live’ through the proprietary ALL IN ONE platform, as well as Sponsor Insights, on-demand public and private company presentations, as well as investor strategy videos, all available to watch via on-demand hub partneringONE, both prior and subsequent to Festival Week, which opens on January 11, 2021, and runs for five days, through to January 15.
Further information at: https://informaconnect.com/biotech-showcase/
Click on Cerbios-Pharma ADC Services for detailed information.